Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy

Wenpei Fan(National Institutes of Health), Nan Lü(Nanjing General Hospital of Nanjing Military Command), Zheyu Shen(National Institutes of Health), Wei Tang(National Institutes of Health), Bo Shen(Fudan University), Zhaowen Cui(Chinese Academy of Sciences), Lingling Shan(National Institutes of Health), Zhèn Yáng(National Institutes of Health), Zhantong Wang(National Institutes of Health), Orit Jacobson(National Institutes of Health), Zijian Zhou(National Institutes of Health), Yijing Liu(National Institutes of Health), Ping Hu(Chinese Academy of Sciences), Weijing Yang(National Institutes of Health), Jibin Song(National Institutes of Health), Yang Zhang(King Abdullah University of Science and Technology), Liwen Zhang(King Abdullah University of Science and Technology), Niveen M. Khashab(King Abdullah University of Science and Technology), Maria A. Aronova(National Institutes of Health), Guangming Lu(Nanjing General Hospital of Nanjing Military Command), Xiaoyuan Chen(National Institutes of Health)
Nature Communications
March 18, 2019
Cited by 166Open Access
Full Text

Abstract

Abstract The success of radiotherapy relies on tumor-specific delivery of radiosensitizers to attenuate hypoxia resistance. Here we report an ammonia-assisted hot water etching strategy for the generic synthesis of a library of small-sized (sub-50 nm) hollow mesoporous organosilica nanoparticles (HMONs) with mono, double, triple, and even quadruple framework hybridization of diverse organic moieties by changing only the introduced bissilylated organosilica precursors. The biodegradable thioether-hybridized HMONs are chosen for efficient co-delivery of tert -butyl hydroperoxide (TBHP) and iron pentacarbonyl (Fe(CO) 5 ). Distinct from conventional RT, radiodynamic therapy (RDT) is developed by taking advantage of X-ray-activated peroxy bond cleavage within TBHP to generate •OH, which can further attack Fe(CO) 5 to release CO molecules for gas therapy. Detailed in vitro and in vivo studies reveal the X-ray-activated cascaded release of •OH and CO molecules from TBHP/Fe(CO) 5 co-loaded PEGylated HMONs without reliance on oxygen, which brings about remarkable destructive effects against both normoxic and hypoxic cancers.


Related Papers

No related papers found

Powered by citation graph analysis